scholarly journals The Association of Opioid Use Disorder and COVID-19 in Shahroud, Iran

Author(s):  
Zhaleh Jamali ◽  
Mohammad Hassan Emamian ◽  
Hassan Hashemi ◽  
Akbar Fotouh

AbstractBackgroundCOVID-19 quickly spread to the world, causing a pandemic. While some studies have found no link between Opioid Use Disorder (OUD) and COVID-19, the role of the opioid on COVID-19 is challenging. The present study aimed to determine the relationship between OUD and COVID-19.MethodsThis was a prospective cohort study. We used data from the third phase of the Shahroud eye cohort study on 4394 participants which started in September 2019 and ended before the COVID-19 epidemic in Shahroud in February 2020. The participants were followed for 10.5 months till November 2020. COVID-19 was detected by RT-PCR on swap samples from the oropharynx and nasopharynx. The incidence of COVID-19 compared in OUD and Non-OUD participants, and relative risk was calculated in Log Binomial Regression model.ResultsAmong the 4394 participants with a mean age of 61.1 years, 120 people had OUD. The incidence of COVID-19 in participants with OUD and Non-OUD were 3.3% and 4.5%, respectively. The relative risk of OUD for COVID-19 was 0.75 (95% Confidence intervals: 0.28 – 1.98; P= 0.555).ConclusionsOpioid use disorder was not associated with COVID-19. The claim that people with OUD are less likely to develop COVID-19 is not supported by this data.

2020 ◽  
Vol 34 (4) ◽  
pp. 265-274
Author(s):  
Mykal J. Leslie ◽  
Kathleen Sheppard-Jones ◽  
Malachy L. Bishop

PurposeThe profession of rehabilitation counseling has long been responsive to emerging disabilities. To date, however, the profession's attention and response to the ongoing opioid crisis in the United States has been incommensurate with the scope and detriment of opioids and opioid use disorder (OUD) on Americans with disabilities. The opioid crisis, including the overuse, abuse, and overdose rates associated with prescription and illegal opioids, affects people of all ages and backgrounds. However, people with disabilities are at increased risk for developing OUDs, and they experience greater barriers to OUD treatment than people without disabilities.MethodThis article describes the origins and development of this crisis, the relationship between disability and increased risk for OUD, and the barriers to treatment that exist. We then evaluate the role of rehabilitation counseling, including the need for further action in advocacy, research, education, and policy.Results and ConclusionsThroughout this article, we encourage a more urgent and concerted response than seems to be the case presently.


Author(s):  
Doran George

This chapter looks at the relationship between Somatics training and the concert stage where its influence on dancers was increasingly evident. Focusing on New York City specifically, the chapter identifies three phases where Somatics impacted performance differently: first, as signaling the dancer’s real-time efforts to construct the dance in performance; second, as providing novel sources of movement; and third, as displaying a new standard of virtuosity. The chapter shows how in each of these phases the relationship of the choreographer to the performer shifted. In the first phase the choreographer and dancer were one and the same, processing the dance in real time, and this was seen as a radical alternative to midcentury modernist approaches in which the dancers showcased the choreographer’s vision. In the second phase, dancers deployed Somatics to demonstrate new vocabularies of movement and new ways of moving, not so much as a way to focus on dance making as to establish their unique artistic voices. In the third phase, the role of the choreographer was restored as the author of the dance, separate from the dancers, who then displayed the choreographer’s vision.


2021 ◽  
Vol 10 (1) ◽  
pp. 15-40
Author(s):  
Archana Prasad

This article explores some questions arising from recent debates on patriarchy and capitalism. The focus is on the role of women in communist-led peasant movements in India and the implications of such struggles on the project of women’s emancipation. The first section lays out a framework for discussing the interface between class consciousness and the anti-patriarchal project, whereby patriarchy is located within the structural contradictions arising out of the contestations within the process of accumulation. The second section documents the historical context, focusing on the relationship between land reforms and social transformation in semi-feudal and early capitalist contexts, and analyzes the extent to which communist-led struggles are anti-patriarchal in character. The third section turns to the participation of women in the contemporary struggles of both agricultural workers and peasant movements and underlines the new emerging dialectics between women’s and peasant organizations under a neoliberal state and with deepening agrarian distress.


2021 ◽  
Author(s):  
Joseph G Pickard ◽  
Carissa van den Berk-Clark ◽  
Monica M Matthieu

ABSTRACT Background Medication-assisted treatment has been shown to be effective in treating opioid use disorder among both older adults and veterans of U.S. Armed Forces. However, limited evidence exists on MAT’s differential effect on treatment completion across age groups. This study aims to ascertain the role of MAT and age in treatment completion among veterans seeking treatment in non–Department of Veterans Affairs healthcare facilities for opioid use disorder. Methods We used the Treatment Episode Data Set—Discharges (TEDS-D; 2006-2017) to examine trends in treatment and MAT usage over time and TEDS-2017 to determine the role of age and MAT in treatment completion. We examined a subset of those who self-identified as veterans and who sought treatment for an opioid use disorder. Results Veterans presented in treatment more often as heroin users than prescription opioid users, and older veterans were more likely to get MAT than younger veterans. We found that before propensity score matching, MAT initially appeared to be associated with a lower likelihood of treatment completion in inpatient ($\beta $ = −1.47, 95% CI −1.56 to −1.39) and outpatient ($\beta $ = −1.40, 95% CI −2.21 to −0.58) settings, and age (50+ years) appeared to mediate the effect of MAT on treatment completion ($\beta $ = −0.54, 95% CI −0.87 to −0.21). After matching, older veterans were more likely to complete substance use disorder treatment ($\beta $ = 0.21, 95% CI 0.01-0.42), while age no longer mediated the effect of MAT, and MAT had a significant positive impact on treatment completion in detox settings ($\beta $ = 1.36, 95% CI 1.15-1.50) and inpatient settings ($\beta $ = 1.54, 95% CI 1.37 -1.71). Conclusion The results show that age plays an important role in outpatient treatment completion, while MAT plays an important role in inpatient treatment completion. Implications for veterans are discussed.


2022 ◽  
Vol 4 (1) ◽  
pp. 100489
Author(s):  
Daisy J. Goodman ◽  
Elizabeth C. Saunders ◽  
Julia R. Frew ◽  
Cybele Arsan ◽  
Haiyi Xie ◽  
...  

2021 ◽  
Vol 17 (7) ◽  
pp. 141-152
Author(s):  
Tamoud Modak, MD, DM ◽  
Siddharth Sarkar, MD, MRCPsych ◽  
Yatan Pal Singh Balhara, MD

Opioid use disorder is a major public health problem, and opioid replacement therapy with buprenorphine (BPN) is a clinically effective and evidence-based treatment for it. To deter misuse of the tablet through the injecting route, BPN coformulated with naloxone (BNX) in 4:1 ratio is available in many countries. Despite this, significant diversion and injecting use of the BNX combination has been reported from across the world. In this article, the pharmacological properties of BPN and BNX and the evidence for their diversion are reviewed. Also, a critical examination is made of the evidence supporting the role of naloxone in reducing the agonist effects of BPN when used through the injecting route. Based on this evidence, a hypothesis explaining the continued diversion of BNX has been proposed.


2020 ◽  
Author(s):  
Navin Kumar ◽  
William Oles ◽  
Benjamin A. Howell ◽  
Kamila Janmohamed ◽  
Selena T. Lee ◽  
...  

AbstractBackgroundSocial connections can lead to contagion of healthy behaviors. Successful treatment of patients with opioid use disorder, as well as recovery of their communities from the opioid epidemic, may lay in rebuilding social networks. Strong social networks of support can reinforce the benefits of medication treatments that are the current standard of care and the most effective tool physicians have to fight the opioid epidemic.MethodsWe conducted a systematic review of electronic research databases, specialist journals and grey literature up to August 2020 to identify experimental and observational studies of social network support in patient populations receiving medication for opioid use disorder (MOUD). We place the studies into a conceptual framework of dynamic social networks, examining the role of networks before MOUD treatment is initiated, during the treatment, and in the long-term following the treatment. We analyze the results across three sources of social network support: partner relationships, family, and peer networks. We also consider the impact of negative social connections.ResultsOf 5193 articles screened, 46 studies were identified as meeting inclusion criteria (12 were experimental and 34 were observational). 39 studies indicated that social network support, or lack thereof, had a statistically significant relationship with improved MOUD treatment outcomes. We find the strongest support for the positive impact of family and partner relationships when integrated into treatment attempts. We also identify strong evidence for a negative impact of maintaining contacts with the drug-using network on treatment outcomes.ConclusionsSocial networks significantly shape effectiveness of opioid use disorder treatments. While negative social ties reinforce addiction, positive social support networks can amplify the benefits of medication treatments. Targeted interventions to reconstruct social networks can be designed as a part of medication treatment with their effects evaluated in improving patients’ odds of recovery from opioid use disorder and reversing the rising trend in opioid deaths.


2020 ◽  
pp. 228-240
Author(s):  
Christopher J. Insole

This chapter shows how central it is, for Kant, that the concept of God only comes downstream from, and after, the possibility of belief in the ‘moral world’. This moral world is the realm of freedom, wherein autonomy is possible. Only if (deterministic) space and time do not go ‘all the way down’, are freedom, and autonomy, possible. If space and time are ‘things-in-themselves’, Kant asserts, ‘then freedom cannot be saved’ (A536/B564). Only if there is a dimension of reality beyond mechanism, is end-setting, and so autonomy, and the highest good possible. Not even God could achieve the highest good in a universe without end-setting, and without freedom, because this universe would be a sort of ‘desert’ with no ‘inner value’. The sequence of thought we find, both in the second Critique, and in other texts is this: first of all, Kant identifies a need for happiness in proportion to virtue; then Kant identifies the obstacle to the realization of such happiness, which is the mechanistic and deterministic structure of nature; and then Kant moves to the solution, which involves leaning into the realm of freedom, which realm includes God. The significance of the third phase in the progression of thought (the realm of freedom) has not been sufficiently considered, it is argued, when considering the Kant’s ‘moral proof’, and the relationship, for Kant, between morality, the highest good, and God.


Sign in / Sign up

Export Citation Format

Share Document